Document is current
Any future updates will be listed below
-
Authors
Ayano, Masahiro https://orcid.org/0000-0002-2954-9676
Hirata, Akie https://orcid.org/0000-0003-4211-3356
Tokunaga, Shoji https://orcid.org/0000-0002-7460-6828
Furuhashi, Hiroko https://orcid.org/0000-0001-5878-0001
Kimoto, Yasutaka https://orcid.org/0000-0002-0158-2917
Ono, Nobuyuki https://orcid.org/0000-0003-0709-4858
Arinobu, Yojiro https://orcid.org/0000-0003-3485-2378
Nakashima, Naoki https://orcid.org/0000-0003-4926-8772
Akashi, Koichi https://orcid.org/0000-0001-7763-5723
Horiuchi, Takahiko https://orcid.org/0000-0002-1770-1087
Niiro, Hiroaki https://orcid.org/0000-0003-0914-9066
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP23K06868)
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 6 April 2024
First Online: 26 April 2024
Declarations
:
: MA and HN received lecture fees from GlaxoSmithKline. All other authors declare that they have no competing interests.
: This study was approved by the ethics committee of Kyushu University Hospital (Fukuoka, Japan; approval number 22275–00) and was conducted in accordance with the principles of the Declaration of Helsinki. Owing to the retrospective nature of the study, all study information was disclosed at the site of related facilities. The requirement of informed consent was waived based on the committee’s guidelines.
